About Saladax
Saladax is a Healthcare company based in Bethlehem (United States) founded in 2004 by Salvatore J Salamone. Diagnostic tests for personalized oncology chemotherapy are provided. Saladax has raised $46.32 million across 6 funding rounds from investors including Fosun Pharmaceutical, GE Capital and Ben Franklin Technology Partners. Its chief executive, as recorded, is Salvatore J Salamone. Saladax offers products and services including 5-Fluorouracil Assay and Clozapine Assay. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its legal entity is SALADAX BIOMEDICAL, INC. Its competitors include Denali Therapeutics, Poseida Therapeutics and Castle Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2004 and based in Bethlehem, United States, Saladax Biomedical operates in the oncology sector. MyCare diagnostic blood tests are developed and offered to enable individualized chemotherapy dosing for patients. This approach is intended to enhance treatment outcomes while minimizing toxic side effects. Companion diagnostics are co-developed with pharmaceutical companies to support drug efficacy in clinical development.
- Headquarters Bethlehem, United States
- Founders Salvatore J Salamone
- SectorsHealthcare
- Website saladax.com
- Social LinkedIn X Facebook YouTube
- Legal Name Saladax Biomedical, Inc
- Total Equity Funding$46.32M (USD)
in 6 rounds
- Latest Funding Round$22.93M (USD), Series D
Sep 2013
- InvestorsFosun Pharmaceutical
& 5 more
Products & Services of Saladax
Saladax offers a comprehensive portfolio of products and services, including 5-Fluorouracil Assay and Clozapine Assay.
Monitors chemotherapy drug levels for optimal patient dosing
Assesses psychiatric medication levels to ensure effective treatment
Apps and channels of Saladax
its YouTube channel Saladax Biomedical has 11 subscribers and 11 videos.
Videos from Saladax
The most watched videos on Saladax's YouTube channel, Saladax Biomedical (11 subscribers). Click a video to play it here.
More on Saladax Biomedical.
Funding Insights of Saladax
Saladax has successfully raised a total of $46.32M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $22.93 million completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $46.32M
- Total Rounds 6
- Last Round Series D — $22.93M
- First Round $3.5M
(Nov 2007)
- Investors Count 6
All 6 funding rounds of Saladax with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2013 | $22.93M | Series D | – | – | |
| Jun 2011 | $9M | Debt – Conventional | – | – | |
| Mar 2010 | $8.4M | Series C | – | – | |
| Oct 2009 | $7.92M | Series B | – | – | – |
| Aug 2008 | $3.57M | Series A | – | – | – |
| Nov 2007 | $3.5M | Series A | – | – | – |
6 investors in total: 6 institutional.
Investors in Saladax
Saladax has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Fosun Pharmaceutical, GE Capital and Ben Franklin Technology Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech & Life-Sciences focused VC Firm investing in the US | goldenseeds.com | New York, United States | ||
Investment and support are provided for Pennsylvania's tech-based companies. | 1983 | benfranklin.org | State College, United States | |
Early to late stage VC firm investing in the US | excelvm.com | Boston, United States | ||
Early-stage investments are made in life sciences technologies. | lsgpa.com | Harrisburg, United States | ||
Research, development, production, and sale of pharmaceuticals are provided. | 1994 | fosunpharma.com | Shanghai, China | |
Commercial aircraft and equipment leasing and lending services are provided. | 1932 | gecapital.com | United States |
Investor details for Saladax
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Saladax
19 people are tracked at Saladax (5 in leadership, 14 in board & advisors).
| Name | Role | Group |
|---|---|---|
Salvatore J Salamone | Founder & CEO | Leadership |
Mary Rose Hilaire | Senior Director, Research & Development | Leadership |
Maria Serieno-Foster | Chief Commercial Officer | Leadership |
Amy Orcutt | Director, Regulatory & Quality | Leadership |
Jeff Wisnoski | Director of Operations & Product Support | Leadership |
William Clarke | Scientific Advisor | Board & advisors |
Howard McLeod | Scientific Advisor | Board & advisors |
Rick Blume | Director | Board & advisors |
Jenny Jiang | Director | Board & advisors |
David M. Brewer | Chairman | Board & advisors |
Michael Esposito | Director | Board & advisors |
Edward Chu | Scientific Advisor | Board & advisors |
John M. Kane | Scientific Advisor | Board & advisors |
Alec Goldenberg | Scientific Advisor | Board & advisors |
Li Zhang | Scientific Advisor | Board & advisors |
Ralph Aquila | Scientific Advisor | Board & advisors |
Joanne Spadoro | Director | Board & advisors |
Ivy Sun | Director | Board & advisors |
David Taylor | Scientific Advisor | Board & advisors |
Complete people profiles for Saladax
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Saladax
3 dated milestones of Saladax across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Saladax is founded.
- Funding First funding round of $3.5M.
- Funding Latest funding round, Series D, of $22.9M.
Competitors of Saladax
Saladax has 3 listed competitors in our database, 3 of them funded. They include Denali Therapeutics, Poseida Therapeutics and Castle Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| cernostics.com | 2008 | Pittsburgh, United States | $14.18M | 16 | Precision diagnostic and prognostic tests are developed by Castle Biosciences. |
Detailed competitors of Saladax
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Saladax
The website of Saladax (saladax.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 20.8% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Saladax (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Saladax
Complete news archive for Saladax
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saladax
Saladax was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Saladax is headquartered in Bethlehem, United States.
Salvatore J Salamone is the CEO of Saladax, as recorded in our data. They have also founded this company.
Saladax is a funded company, having raised a total of $46.32M across 6 funding rounds to date. The company's 1st funding round was a Series A of $3.5M, raised on Nov 2007.
Founded in 2004 and based in Bethlehem, United States, Saladax Biomedical operates in the oncology sector. MyCare diagnostic blood tests are developed and offered to enable individualized chemotherapy dosing for patients. This approach is intended to enhance treatment outcomes while minimizing toxic side effects. Companion diagnostics are co-developed with pharmaceutical companies to support drug efficacy in clinical development.
Saladax's top competitors include Poseida Therapeutics, Denali Therapeutics and Castle Biosciences.
Saladax offers 5-Fluorouracil Assay and Clozapine Assay.
Saladax has 6 investors. Key investors include Fosun Pharmaceutical, GE Capital, Ben Franklin Technology Partners, Golden Seeds, and Excel Venture Management.
Saladax operates through Saladax Biomedical, Inc.